Literature DB >> 10971540

The effects of chronic otitis media with effusion on the measurement of distortion products of otoacoustic emissions: presurgical and postsurgical examination.

M M Topolska1, E Hassman, M Baczek.   

Abstract

This study aims to determine the influence of middle ear effusion and inserted tympanostomy tubes on the feasibility of recording and of the amplitude of distortion product otoacoustic emissions (DPOAE). Effusion in the middle ear reduces the number of measurable responses and their amplitude in the whole range of frequencies from 0.5 to 8 kHz. These changes were more distinct in mucous than in serous effusion. There was an increase in the number of measurable responses and amplitude of DPOAE after surgery. Inserted tympanostomy tubes have no influence on the feasibility of DPOAE recording but reduce their amplitude in comparison to the control group.

Entities:  

Mesh:

Year:  2000        PMID: 10971540     DOI: 10.1046/j.1365-2273.2000.00377.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  4 in total

1.  [The influence of conductive hearing loss on DPOAE-threshold. The effect of an individually optimized stimulation].

Authors:  P Kummer; E M Schuster; F Rosanowski; U Eysholdt; J Lohscheller
Journal:  HNO       Date:  2006-06       Impact factor: 1.284

2.  Otoacoustic Emissions in Otitis Media with Effusion: Do They Carry any Clinical Significance?

Authors:  J S Thakur; Ishan Chauhan; N K Mohindroo; D R Sharma; R K Azad; M S Vasanthalakshmi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-10-30

3.  Audiologic Profiles of Children With Otitis Media With Effusion.

Authors:  Sarah Al-Salim; Richard M Tempero; Hannah Johnson; Gabrielle R Merchant
Journal:  Ear Hear       Date:  2021 Sep/Oct       Impact factor: 3.562

4.  Contrasting Effects of Pressure Compensation on TEOAE and DPOAE in Children With Negative Middle Ear Pressure.

Authors:  Snezana A Filipović; Mark P Haggard; Helen Spencer; Goran Trajković
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.